While the role of chimeric antigen receptor (CAR) T-cell therapy has expanded into earlier lines of therapy for patients with multiple myeloma (MM), providers are faced with new opportunities and challenges to individualizing care. Join leading MM experts in this interactive webinar, which will divulge real-world challenges to the optimal integration of CAR T-cell therapy in earlier lines of MM care identified through a new hematology/oncology provider survey. The expert faculty will then take the audience through complex clinical cases, sharing real-world perspectives with various "what if" scenarios to explore key nuances of decision-making regarding selection and management of CAR T-cell treatment. Wrapping up with a live question and answer session, this webinar is designed to equip you with evidence-based strategies to optimize CAR T-cell therapy as an earlier treatment option for patients with MM.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/expert-strategies-optimize-integration-car-t-cell-therapy-into-earlier-lines
- Start Date: 2025-03-04 06:00:00
- End Date: 2025-03-04 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: janssen - Amount: 0.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all